Modified vaccinia Ankara

Vaccinia viruses re-engineered to express foreign genes are robust vectors for production of recombinant proteins, the most common being a vaccine delivery system for antigens. Concerns about the safety of the vaccinia virus have been addressed by the development of vectors based on attenuated vaccinia viruses. One of them, the Modified Vaccinia Ankara (MVA) virus, is a highly attenuated strain of vaccinia virus that was developed towards the end of the campaign for the eradication of smallpox by Professor Anton Mayr in Germany. Produced by hundreds of passages of vaccinia virus in chicken cells, MVA has lost about 10% of the vaccinia genome and with it the ability to replicate efficiently in primate cells.

Modified vaccinia Ankara in clinical trials

MVA is widely considered as the vaccinia virus strain of choice for clinical investigation because of its high safety profile. MVA has been administered to numerous animal species including monkeys, mice, swine, sheep, cattle, horses, and elephants, with no local or systemic adverse effects. Over 120,000 humans have been safely and successfully vaccinated against smallpox with MVA by intradermal, subcutaneous, or intramuscular injections. Currently, the use of MVA as a recombinant HIV vaccine (MVA-B) is being tested in approximately 300 volunteers in several Phase I studies conducted by the International AIDS Vaccine Initiative. Studies in mice and nonhuman primates have further demonstrated the safety of MVA under conditions of immune suppression.

Recently, vaccination with smallpox vaccine (a vaccinia virus related to MVA) has been shown, on rare occasions, to cause heart problems in people who received it: heart inflammation (myocarditis), inflammation of the membrane covering the heart (pericarditis), and a combination of these two problems (myopericarditis). A few cases of cardiac chest pain (angina) and heart attack have also been reported following smallpox vaccination. It is not known at this time if smallpox vaccination causes angina or heart attacks. MVA is an attenuated vaccinia virus and does not replicate in the human body as efficiently as vaccinia. However, whether MVA can induce the same side effects as vaccinia is not known at this time.

Compared to replicating vaccinia viruses, MVA provides similar or higher levels of recombinant gene expression even in non-permissive cells. In animal models, recombinant MVA vaccines have been found immunogenic and to protect against various infectious agents including influenza, parainfluenza, measles virus, flaviviruses, and plasmodium parasites.

Immunogenicity

In animal models, MVA vaccines have been found to be immunogenic and protective against various infectious agents including immunodeficiency viruses, influenza, parainfluenza, measles virus, flaviviruses, tuberculosis, Plasmodium parasites and smallpox.

A considerable amount of data on MVA vector vaccines has been accumulated from studies in macaques.

In addition, combinations of viral vector vaccines have been employed successfully. Studies in mice show that fowlpox-based and MVA-based vaccines used in combination induce immunity and protection against challenge with Plasmodium parasites. In macaques, DNA-based HIV vaccines can be effectively boosted with recombinant MVA-based vaccines expressing HIV antigens.

Challenge Studies in Primates

Immunization regimens incorporating priming with DNA vaccine and boosting with recombinant MVA-based vaccine have been found to provide some protection in non-human primates following challenge with an immunodeficiency virus. While vaccination did not prevent infection in these studies, it did result in lower viral load setpoints, increased CD4 counts, and reduced morbidity and mortality in vaccinated animals, compared to controls.


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • MVA-B — MVA B, or Modified Vaccinia Ankara B, is a particular HIV vaccine created to give immune resistance to infection by the HIV virus. It was developed by a team of Spanish researchers at the Spanish National Research Council s Biotechnology National …   Wikipedia

  • MVA85A — (modified vaccinia Ankara 85A) is a new generation vaccine against tuberculosis developed by researchers at Oxford University. This vaccine produces higher levels of long lasting cellular immunity when used together with the old TB vaccine called …   Wikipedia

  • MVA — may stand for:*MTV Video Music Awards *Manual vacuum aspiration, a method of abortion that consists of removing the embryo by suction *Market Value Accounting, an alternative accounting method used by banks *Market value added, an economic metric …   Wikipedia

  • HIV vaccine — An HIV vaccine is a hypothetical vaccine against HIV, the etiological agent of AIDS. As there is no known cure for AIDS, the search for a vaccine has become part of the struggle against the disease.The urgency of the search for a vaccine against… …   Wikipedia

  • GeoVax — is a biotechnology company established primarily to develop an effective and safe vaccine against HIV 1, although ultimately the company is to create vaccines for many serious human diseases for which none currently exist. Corporate History… …   Wikipedia

  • MVA — mechanical ventricular assistance; mevalonic acid; mitral valve area; modified vaccinia virus Ankara; Modified Virus Ankara; motor vehicle accident …   Medical dictionary

  • MVA — • mechanical ventricular assistance; • mevalonic acid; • mitral valve area; • modified vaccinia virus Ankara; • Modified Virus Ankara; • motor vehicle accident …   Dictionary of medical acronyms & abbreviations

  • TroVax — is a cancer vaccine being developed by Oxford BioMedica. No cancer vaccines have been proven to cure cancer or extend life yet, [ [http://www.cancer.gov/cancertopics/factsheet/cancervaccine National Cancer Institute, Cancer Vaccine Fact Sheet,]… …   Wikipedia

  • MVA — Motor Vehicle Accident (Medical » Physiology) Market Value Adjustment (Business » Stock Exchange) Motor Vehicle Administration (Governmental) *** Modified Vaccinia virus Ankara (Medical » Physiology) *** Market Value Added (Business » Accounting) …   Abbreviations dictionary

  • Virus de la inmunodeficiencia humana —   Virus de la inmunodeficiencia humana (VIH) …   Wikipedia Español


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.